GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valerio Therapeutics (XPAR:ALVIO) » Definitions » Other Current Receivables

Valerio Therapeutics (XPAR:ALVIO) Other Current Receivables : €0.03 Mil (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Valerio Therapeutics Other Current Receivables?

Valerio Therapeutics's Other Current Receivables for the quarter that ended in Jun. 2024 was €0.03 Mil.

Valerio Therapeutics's quarterly Other Current Receivables declined from Jun. 2023 (€0.01 Mil) to Dec. 2023 (€0.01 Mil) but then increased from Dec. 2023 (€0.01 Mil) to Jun. 2024 (€0.03 Mil).

Valerio Therapeutics's annual Other Current Receivables declined from Dec. 2021 (€0.01 Mil) to Dec. 2022 (€0.01 Mil) but then stayed the same from Dec. 2022 (€0.01 Mil) to Dec. 2023 (€0.01 Mil).


Valerio Therapeutics Other Current Receivables Historical Data

The historical data trend for Valerio Therapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valerio Therapeutics Other Current Receivables Chart

Valerio Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.16 0.01 0.01 0.01 0.01

Valerio Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.03

Valerio Therapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Valerio Therapeutics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Valerio Therapeutics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Valerio Therapeutics Business Description

Traded in Other Exchanges
Address
49 Boulevard du General, Martial Valin, Paris, FRA, 75015
Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

Valerio Therapeutics Headlines

No Headlines